Liver cancer cells
Lampiasi, N., Azzolina, A., Umezawa, K., Montalto, G., McCubrey, J.A., Cervello, M. (2012). The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. CANCER LETTERS, 322(1), 35-44 [10.1016/j.canlet.2012.02.008].
The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.
MONTALTO, Giuseppe;
2012-01-01
Abstract
Liver cancer cells
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Lampiasi N et al - Cancer Letters 2012.pdf
Solo gestori archvio
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
